Radiation Dosimetry of 99mTc-PSMA I&S: A Single-Center Prospective Study

Conclusion: Effective doses of 99mTc-PSMA I&S were comparable to those known for most of the 99mTc tracers and was lower than for the 68Ga-labeled and 18F-labeled agents. 99mTc-PSMA I&S SPECT/CT showed high TBR in PCa patients. This study can provide required data for translation and approval of 99mTc-PSMA I&S by regulatory agencies.

Source: Journal of Nuclear Medicine - July 30, 2021 Category: Nuclear Medicine Authors: Urban, S., Meyer, C., Dahlbom, M., Farkas, I., Sipka, G., Besenyi, Z., Czernin, J., Calais, J., Pavics, L. Tags: Clinical Investigations Source Type: research